U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805369) titled 'A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer' on Sept. 01.
Brief Summary: This is a first-in-human Phase 1 study of DEM301 in adults with previously treated advanced metastatic colorectal cancer. DEM301 is an investigational antibody-drug conjugate. The study will evaluate the safety and tolerability of DEM301, identify doses for further study, and assess how the drug behaves in the body and whether it shows signs of activity against the cancer.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Metastatic Colorectal Cancer
Colon Cancer
Rectal Cancer
Intervention:
DRUG: DEM301
D...